Literature DB >> 18756004

ACTN3 genotype is associated with muscle phenotypes in women across the adult age span.

Sean Walsh1, Dongmei Liu, E Jeffrey Metter, Luigi Ferrucci, Stephen M Roth.   

Abstract

The R577X polymorphism in the alpha-actinin-3 encoding gene (ACTN3) has been associated with elite athletic performance, and recently with differences in isometric and dynamic muscle strength and power in the general population. In this study we sought to determine the association of ACTN3 R577X genotype with muscle strength and mass phenotypes in men and women across the adult age span. Eight hundred forty-eight (n = 848) adult volunteers (454 men and 394 women) aged 22-90 yr were genotyped for ACTN3 R577X. Knee extensor (KE) shortening and lengthening peak torque values were determined using isokinetic dynamometry and fat-free mass (FFM) by dual-energy X-ray absorptiometry. Women deficient in alpha-actinin-3 (X/X; n = 53) displayed lower KE shortening peak torque (30 degrees /s: 89.5 +/- 3.5 vs. 99.3 +/- 1.4 N.m, P = 0.011; 180 degrees /s: 60.3 +/- 2.6 vs. 67.0 +/- 1.0 N.m, P = 0.019) and KE lengthening peak torque (30 degrees /s: 122.8 +/- 5.7 vs. 137.0 +/- 2.2 N.m, P = 0.022; 180 degrees /s: 121.8 +/- 5.8 vs. 138.5 +/- 2.2 N.m, P = 0.008) compared with R/X + R/R women (n = 341). Women X/X homozygotes also displayed lower levels of both total body FFM (38.9 +/- 0.5 vs. 40.1 +/- 0.2 kg, P = 0.040) and lower limb FFM (11.9 +/- 0.2 vs. 12.5 +/- 0.1 kg, P = 0.044) compared with R/X + R/R women. No genotype-related differences were observed in men. In conclusion, our results indicate that the absence of alpha-actinin-3 protein (i.e., ACTN3 X/X genotype) influences KE peak torque and FFM in women but not men.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18756004      PMCID: PMC2584847          DOI: 10.1152/japplphysiol.90856.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  33 in total

1.  The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults.

Authors:  Elisabeth F C van Rossum; Paul G Voorhoeve; Saskia J te Velde; Jan W Koper; Henriette A Delemarre-van de Waal; Han C G Kemper; Steven W J Lamberts
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

Review 2.  Regulation of skeletal muscle fiber size, shape and function.

Authors:  V R Edgerton; R R Roy
Journal:  J Biomech       Date:  1991       Impact factor: 2.712

3.  Association of the type I collagen alpha1 Sp1 polymorphism, bone density and upper limb muscle strength in community-dwelling elderly men.

Authors:  I Van Pottelbergh; S Goemaere; L Nuytinck; A De Paepe; J M Kaufman
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

Review 4.  The structure and function of alpha-actinin.

Authors:  A Blanchard; V Ohanian; D Critchley
Journal:  J Muscle Res Cell Motil       Date:  1989-08       Impact factor: 2.698

5.  Muscle strength and body mass index as long-term predictors of mortality in initially healthy men.

Authors:  T Rantanen; T Harris; S G Leveille; M Visser; D Foley; K Masaki; J M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-03       Impact factor: 6.053

6.  Interleukin-6 (IL6) genotype is associated with fat-free mass in men but not women.

Authors:  Stephen M Roth; Matthew A Schrager; Mechele R Lee; E Jeffrey Metter; Ben F Hurley; Robert E Ferrell
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-12       Impact factor: 6.053

7.  Skeletal muscle strength as a predictor of all-cause mortality in healthy men.

Authors:  E Jeffrey Metter; Laura A Talbot; Matthew Schrager; Robin Conwit
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-10       Impact factor: 6.053

8.  ACTN3 genotype is associated with human elite athletic performance.

Authors:  Nan Yang; Daniel G MacArthur; Jason P Gulbin; Allan G Hahn; Alan H Beggs; Simon Easteal; Kathryn North
Journal:  Am J Hum Genet       Date:  2003-07-23       Impact factor: 11.025

Review 9.  A gene for speed? The evolution and function of alpha-actinin-3.

Authors:  Daniel G MacArthur; Kathryn N North
Journal:  Bioessays       Date:  2004-07       Impact factor: 4.345

10.  A gene for speed: contractile properties of isolated whole EDL muscle from an alpha-actinin-3 knockout mouse.

Authors:  S Chan; J T Seto; D G MacArthur; N Yang; K N North; S I Head
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-23       Impact factor: 4.249

View more
  41 in total

Review 1.  Effects of aging, exercise, and disease on force transfer in skeletal muscle.

Authors:  David C Hughes; Marita A Wallace; Keith Baar
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-05-12       Impact factor: 4.310

Review 2.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

3.  ACE I/D, ACTN3 R577X, PPARD T294C and PPARGC1A Gly482Ser polymorphisms and physical fitness in Taiwanese late adolescent girls.

Authors:  Li-Ling Chiu; Tzu-Wen Chen; Sandy S Hsieh; Ling-Ling Hsieh
Journal:  J Physiol Sci       Date:  2012-01-14       Impact factor: 2.781

Review 4.  Rodent models for resolving extremes of exercise and health.

Authors:  Fleur C Garton; Kathryn N North; Lauren G Koch; Steven L Britton; Gisela Nogales-Gadea; Alejandro Lucia
Journal:  Physiol Genomics       Date:  2015-09-22       Impact factor: 3.107

Review 5.  Molecular genetic studies of gene identification for sarcopenia.

Authors:  Li-Jun Tan; Shan-Lin Liu; Shu-Feng Lei; Christopher J Papasian; Hong-Wen Deng
Journal:  Hum Genet       Date:  2011-06-26       Impact factor: 4.132

Review 6.  Genes and the ageing muscle: a review on genetic association studies.

Authors:  Nuria Garatachea; Alejandro Lucía
Journal:  Age (Dordr)       Date:  2011-10-27

7.  Does the ACE I/D polymorphism, alone or in combination with the ACTN3 R577X polymorphism, influence muscle power phenotypes in young, non-athletic adults?

Authors:  Gabriel Rodríguez-Romo; Jonatan R Ruiz; Catalina Santiago; Carmen Fiuza-Luces; Marta González-Freire; Félix Gómez-Gallego; María Morán; Alejandro Lucia
Journal:  Eur J Appl Physiol       Date:  2010-08-24       Impact factor: 3.078

8.  SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.

Authors:  E Pegoraro; E P Hoffman; L Piva; B F Gavassini; S Cagnin; M Ermani; L Bello; G Soraru; B Pacchioni; M D Bonifati; G Lanfranchi; C Angelini; A Kesari; I Lee; H Gordish-Dressman; J M Devaney; C M McDonald
Journal:  Neurology       Date:  2010-12-22       Impact factor: 9.910

9.  ACTN3 genotype influences muscle performance through the regulation of calcineurin signaling.

Authors:  Jane T Seto; Kate G R Quinlan; Monkol Lek; Xi Fiona Zheng; Fleur Garton; Daniel G MacArthur; Marshall W Hogarth; Peter J Houweling; Paul Gregorevic; Nigel Turner; Gregory J Cooney; Nan Yang; Kathryn N North
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

10.  CNTF 1357 G -> A polymorphism and the muscle strength response to resistance training.

Authors:  Sean Walsh; Bethany K Kelsey; Theodore J Angelopoulos; Priscilla M Clarkson; Paul M Gordon; Niall M Moyna; Paul S Visich; Robert F Zoeller; Richard L Seip; Steve Bilbie; Paul D Thompson; Eric P Hoffman; Thomas B Price; Joseph M Devaney; Linda S Pescatello
Journal:  J Appl Physiol (1985)       Date:  2009-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.